A detailed history of Fmr LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Fmr LLC holds 5,281,023 shares of LUNG stock, worth $38.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,281,023
Previous 4,853,935 8.8%
Holding current value
$38.9 Million
Previous $45 Million 25.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.77 - $9.82 $2.46 Million - $4.19 Million
427,088 Added 8.8%
5,281,023 $33.5 Million
Q1 2024

May 13, 2024

BUY
$8.71 - $14.65 $13.5 Million - $22.6 Million
1,544,434 Added 46.67%
4,853,935 $45 Million
Q4 2023

Feb 13, 2024

BUY
$7.89 - $13.14 $10.1 Million - $16.8 Million
1,279,666 Added 63.04%
3,309,501 $42.2 Million
Q3 2023

Nov 13, 2023

BUY
$9.88 - $14.0 $3.97 Million - $5.63 Million
401,830 Added 24.68%
2,029,835 $21 Million
Q2 2023

Aug 11, 2023

BUY
$10.78 - $13.65 $7.17 Million - $9.08 Million
665,507 Added 69.14%
1,628,005 $21.3 Million
Q1 2023

May 11, 2023

BUY
$7.49 - $12.54 $6.94 Million - $11.6 Million
927,223 Added 2628.56%
962,498 $10.8 Million
Q4 2022

Feb 13, 2023

SELL
$4.92 - $17.35 $31,812 - $112,185
-6,466 Reduced 15.49%
35,275 $297,000
Q3 2022

Nov 10, 2022

BUY
$15.35 - $23.99 $8,657 - $13,530
564 Added 1.37%
41,741 $695,000
Q2 2022

Aug 12, 2022

SELL
$14.0 - $27.95 $3,934 - $7,853
-281 Reduced 0.68%
41,177 $606,000
Q1 2022

May 13, 2022

SELL
$21.13 - $35.65 $9.29 Million - $15.7 Million
-439,796 Reduced 91.39%
41,458 $1.03 Million
Q4 2021

Feb 14, 2022

SELL
$29.72 - $45.1 $104,941 - $159,248
-3,531 Reduced 0.73%
481,254 $15.4 Million
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $7.31 Million - $9.04 Million
203,217 Added 72.17%
484,785 $17.4 Million
Q2 2021

Aug 13, 2021

BUY
$37.61 - $48.0 $10.6 Million - $13.5 Million
281,568 New
281,568 $12.4 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $274M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.